Want to see NPCE full AI Analyst Report?
Rns System
Seizures, Epilepsy, Lennox Gastaut Syndrome, Lennox-Gastaut Syndrome, Intractable, Seizures, Generalized
Phase II
Recruiting
RNS System LGS Feasibility Study
Mar 29, 2022
―
Responsive Stimulation, Sham Stimulation
Epilepsy, Idiopathic Generalized Epilepsy, Generalized Tonic Clonic Seizure
Phase III
Active Not Recruiting
RNS System NAUTILUS Study
Nov 23, 2021
―
FAQ
What are the FDA phases for drug approval?
The FDA approval process for new drugs is divided into several phases:
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
a. Preclinical testing
b. Phase 1 – Safety and dosage
c. Phase 2 – Effectiveness and side effects
d. Phase 3 – Confirmation of effectiveness, monitoring of adverse reactions, and comparison with existing treatments
e. Phase 4 – Post-marketing studies to track long-term safety and effectiveness
What is a clinical trial?
A clinical trial is a carefully designed study in which researchers test a drug, treatment, or medical device in people to evaluate its safety, effectiveness, and potential side effects. These trials are essential for determining whether a new treatment should be approved for widespread use.
What drugs does NeuroPace (NPCE) have in its pipeline
NPCE is currently developing the following drugs: Rns System, Responsive Stimulation, Sham Stimulation. These drug candidates are in various stages of clinical development as the company works toward FDA approval.